The European Medicines Agency (EMA) has recommended this Monday to administer a booster dose with the Pfizer vaccine to the immunosuppressed population at least 28 days after receiving the complete regimen. It also opens the door to consider giving third booster doses of Pfizer or Moderna vaccines to the general population six months after the second dose.
The agency’s committee on human medicines (CHMP) met this Monday to analyze the data sent by the pharmaceutical companies Pfizer / BioNTech on the third dose against COVID-19. Experts have indicated after Studies show that an additional dose of these vaccines increases the ability to produce antibodies against the coronavirus.
Therefore, the Committee has concluded that booster doses are they may consider at least six months after the second dose for people over 18 years of age or older, while it is recommended for people who are immunosuppressed or with diseases that increase the risk of serious disease. It is important to distinguish between the extra dose for people with weakened immune systems and the booster doses for people with normal immune systems.
At the beginning of September, the EMA ruled on administering a third dose to those over 60 years of age or immunosuppressed and Public Health in Spain ratified the decision and began to administer it in nursing homes.